

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 5.94607262 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.08896551 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.08896551 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.08896551 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.08896551 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.08896551 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.08896551 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.61655311 |
| 9 | positive regulation of immune response to tumor cell (GO:0002839) | 4.27718628 |
| 10 | regulation of immune response to tumor cell (GO:0002837) | 4.27718628 |
| 11 | regulation of response to tumor cell (GO:0002834) | 4.27718628 |
| 12 | positive regulation of response to tumor cell (GO:0002836) | 4.27718628 |
| 13 | regulation of RIG-I signaling pathway (GO:0039535) | 4.22464133 |
| 14 | response to host immune response (GO:0052572) | 3.74982151 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.74982151 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.74620805 |
| 17 | negative regulation of necroptotic process (GO:0060546) | 3.70251218 |
| 18 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.62915715 |
| 19 | pinocytosis (GO:0006907) | 3.61688780 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.61584425 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.60721469 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.56785504 |
| 23 | response to peptidoglycan (GO:0032494) | 3.53738875 |
| 24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.51151828 |
| 25 | response to host (GO:0075136) | 3.51151828 |
| 26 | response to host defenses (GO:0052200) | 3.51151828 |
| 27 | amino sugar catabolic process (GO:0046348) | 3.30161388 |
| 28 | regulation of necroptotic process (GO:0060544) | 3.26763032 |
| 29 | detection of biotic stimulus (GO:0009595) | 3.24001868 |
| 30 | myeloid dendritic cell differentiation (GO:0043011) | 3.15533907 |
| 31 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12958654 |
| 32 | regulation of cholesterol homeostasis (GO:2000188) | 3.10465882 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.09657417 |
| 34 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07336242 |
| 35 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.07108502 |
| 36 | glucosamine-containing compound catabolic process (GO:1901072) | 3.06115572 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.04321158 |
| 38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03796778 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97391098 |
| 40 | necroptotic process (GO:0070266) | 2.93691853 |
| 41 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.90436596 |
| 42 | myeloid dendritic cell activation (GO:0001773) | 2.90215135 |
| 43 | cellular response to type I interferon (GO:0071357) | 2.88748773 |
| 44 | type I interferon signaling pathway (GO:0060337) | 2.88748773 |
| 45 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.87747925 |
| 46 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.86718876 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.86431701 |
| 48 | response to type I interferon (GO:0034340) | 2.84929138 |
| 49 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.84065267 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 2.83007282 |
| 51 | negative regulation of fibrinolysis (GO:0051918) | 2.81596019 |
| 52 | positive regulation of protein homooligomerization (GO:0032464) | 2.79518846 |
| 53 | positive regulation of humoral immune response (GO:0002922) | 2.76606298 |
| 54 | oligosaccharide catabolic process (GO:0009313) | 2.76373562 |
| 55 | negative T cell selection (GO:0043383) | 2.75595469 |
| 56 | regulation of gamma-delta T cell activation (GO:0046643) | 2.74707620 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73684674 |
| 58 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.70643435 |
| 59 | tolerance induction (GO:0002507) | 2.68276298 |
| 60 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68010960 |
| 61 | protein localization to endosome (GO:0036010) | 2.67455250 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.65929459 |
| 63 | regulation of interleukin-12 production (GO:0032655) | 2.65879603 |
| 64 | regulation of cholesterol storage (GO:0010885) | 2.64970986 |
| 65 | negative regulation of necrotic cell death (GO:0060547) | 2.64313756 |
| 66 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.64058499 |
| 67 | regulation of response to interferon-gamma (GO:0060330) | 2.61610757 |
| 68 | activated T cell proliferation (GO:0050798) | 2.61028495 |
| 69 | response to laminar fluid shear stress (GO:0034616) | 2.60858671 |
| 70 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.57307133 |
| 71 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.57163722 |
| 72 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.56842266 |
| 73 | positive regulation of interleukin-10 production (GO:0032733) | 2.56421661 |
| 74 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.56122427 |
| 75 | regulation of metalloenzyme activity (GO:0048552) | 2.56058263 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 2.54203280 |
| 77 | autophagic vacuole fusion (GO:0000046) | 2.53895726 |
| 78 | embryonic process involved in female pregnancy (GO:0060136) | 2.50596235 |
| 79 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50474692 |
| 80 | negative regulation of cell killing (GO:0031342) | 2.50474692 |
| 81 | detection of external biotic stimulus (GO:0098581) | 2.50471768 |
| 82 | dendritic cell differentiation (GO:0097028) | 2.49317055 |
| 83 | regulation of interleukin-17 production (GO:0032660) | 2.47931813 |
| 84 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.47008350 |
| 85 | negative regulation of interleukin-17 production (GO:0032700) | 2.46797224 |
| 86 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.46446715 |
| 87 | positive regulation of interleukin-17 production (GO:0032740) | 2.46390577 |
| 88 | programmed necrotic cell death (GO:0097300) | 2.44510107 |
| 89 | lipopolysaccharide metabolic process (GO:0008653) | 2.44349791 |
| 90 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.44027118 |
| 91 | positive regulation of interferon-alpha production (GO:0032727) | 2.43628072 |
| 92 | regulation of interferon-alpha production (GO:0032647) | 2.41211772 |
| 93 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41074878 |
| 94 | T cell apoptotic process (GO:0070231) | 2.38437110 |
| 95 | response to interleukin-15 (GO:0070672) | 2.37964861 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.37406560 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.37406560 |
| 98 | T cell proliferation (GO:0042098) | 2.36804302 |
| 99 | detection of other organism (GO:0098543) | 2.36566462 |
| 100 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.36300405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.28323408 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.89047175 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67594220 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.65052378 |
| 5 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.60589878 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49532136 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40653803 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40520612 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.39036661 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.35505076 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30513602 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25521237 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24845903 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19575564 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.18839670 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.01584129 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97802161 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.92733469 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87810418 |
| 20 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87576744 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86465686 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86148083 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.84746097 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82217974 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80443767 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.77598037 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77569122 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76444022 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73847436 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69668230 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69055505 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68458218 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67616298 |
| 34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67216261 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66967674 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62785359 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61303232 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.59124351 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56884077 |
| 40 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56557226 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55040069 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.54418075 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.52450157 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51474134 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51307523 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.51028377 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.50698385 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47787354 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47506541 |
| 50 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.47134804 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45808754 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44602751 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43537089 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41602512 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40650159 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40607164 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39876555 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37011301 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34765111 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34724364 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31207744 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29756076 |
| 63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29600281 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.28952018 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27656277 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27162340 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26836053 |
| 68 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26025319 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25883462 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23158598 |
| 71 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22269603 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21388688 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.21319736 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20238394 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.17764958 |
| 76 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16078039 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11815290 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11631955 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09956298 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09887192 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09823798 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09377980 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06592723 |
| 84 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04885585 |
| 85 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04715803 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04622529 |
| 87 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04499504 |
| 88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04283788 |
| 89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02720854 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01982219 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01338079 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00496885 |
| 93 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99458103 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.98292923 |
| 95 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97675552 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97187809 |
| 97 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.96994888 |
| 98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95779186 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95501229 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95493769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003191_abnormal_cellular_cholesterol | 3.93899798 |
| 2 | MP0005451_abnormal_body_composition | 3.27898894 |
| 3 | MP0003303_peritoneal_inflammation | 3.22847277 |
| 4 | MP0002163_abnormal_gland_morphology | 3.11643553 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 2.73683074 |
| 6 | MP0000685_abnormal_immune_system | 2.61635820 |
| 7 | MP0009840_abnormal_foam_cell | 2.61429200 |
| 8 | MP0003724_increased_susceptibility_to | 2.60150876 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.55943255 |
| 10 | MP0003436_decreased_susceptibility_to | 2.55249681 |
| 11 | MP0006082_CNS_inflammation | 2.43133501 |
| 12 | MP0005671_abnormal_response_to | 2.41596872 |
| 13 | MP0001348_abnormal_lacrimal_gland | 2.37039394 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.36978178 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.27124924 |
| 16 | MP0008260_abnormal_autophagy | 2.26946693 |
| 17 | MP0002419_abnormal_innate_immunity | 2.18818638 |
| 18 | MP0009785_altered_susceptibility_to | 2.18325310 |
| 19 | MP0001800_abnormal_humoral_immune | 2.14524328 |
| 20 | MP0002723_abnormal_immune_serum | 2.09688900 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.06329107 |
| 22 | MP0005025_abnormal_response_to | 2.04959615 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.98778551 |
| 24 | MP0005387_immune_system_phenotype | 1.92001317 |
| 25 | MP0001790_abnormal_immune_system | 1.92001317 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.90868496 |
| 27 | MP0005310_abnormal_salivary_gland | 1.84318747 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.83544751 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.81818029 |
| 30 | MP0005379_endocrine/exocrine_gland_phen | 1.79086625 |
| 31 | MP0001819_abnormal_immune_cell | 1.79066099 |
| 32 | MP0002420_abnormal_adaptive_immunity | 1.78585040 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.73782050 |
| 34 | MP0004947_skin_inflammation | 1.66376458 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.63075839 |
| 36 | MP0002405_respiratory_system_inflammati | 1.59373547 |
| 37 | MP0009278_abnormal_bone_marrow | 1.58512750 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.54830132 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.53636640 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.51945966 |
| 41 | MP0002398_abnormal_bone_marrow | 1.51635164 |
| 42 | MP0002254_reproductive_system_inflammat | 1.47024537 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.45108369 |
| 44 | MP0000716_abnormal_immune_system | 1.43749269 |
| 45 | MP0001915_intracranial_hemorrhage | 1.37101457 |
| 46 | MP0000858_altered_metastatic_potential | 1.36573692 |
| 47 | MP0008469_abnormal_protein_level | 1.35930642 |
| 48 | MP0002722_abnormal_immune_system | 1.31239043 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.30006192 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.30006192 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.29387987 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.27102883 |
| 53 | MP0002429_abnormal_blood_cell | 1.24706770 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.23920477 |
| 55 | MP0003075_altered_response_to | 1.21211852 |
| 56 | MP0000604_amyloidosis | 1.16399334 |
| 57 | MP0006054_spinal_hemorrhage | 1.15619283 |
| 58 | MP0003828_pulmonary_edema | 1.13861315 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.13359684 |
| 60 | MP0009764_decreased_sensitivity_to | 1.12325760 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.09388670 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.07656042 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.07231601 |
| 64 | MP0002006_tumorigenesis | 1.07159224 |
| 65 | MP0004233_abnormal_muscle_weight | 1.06563350 |
| 66 | MP0000609_abnormal_liver_physiology | 1.06447265 |
| 67 | MP0004381_abnormal_hair_follicle | 1.03927255 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.03788613 |
| 69 | MP0001346_abnormal_lacrimal_gland | 1.02114044 |
| 70 | MP0009763_increased_sensitivity_to | 0.99676318 |
| 71 | MP0001853_heart_inflammation | 0.97517291 |
| 72 | MP0005360_urolithiasis | 0.96484805 |
| 73 | MP0005164_abnormal_response_to | 0.95945640 |
| 74 | MP0008007_abnormal_cellular_replicative | 0.94781381 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.92836842 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.91672530 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.91060888 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.90968676 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.90353476 |
| 80 | MP0001851_eye_inflammation | 0.90230575 |
| 81 | MP0005621_abnormal_cell_physiology | 0.86233433 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 0.84174836 |
| 83 | MP0008057_abnormal_DNA_replication | 0.84114110 |
| 84 | MP0002132_abnormal_respiratory_system | 0.83755764 |
| 85 | MP0003221_abnormal_cardiomyocyte_apopto | 0.80999333 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.80428084 |
| 87 | MP0003866_abnormal_defecation | 0.76654032 |
| 88 | MP0001873_stomach_inflammation | 0.75556366 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.75079593 |
| 90 | MP0005384_cellular_phenotype | 0.73451486 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.73356118 |
| 92 | MP0003091_abnormal_cell_migration | 0.73213994 |
| 93 | MP0000358_abnormal_cell_content/ | 0.73194978 |
| 94 | MP0003195_calcinosis | 0.72356141 |
| 95 | MP0000343_altered_response_to | 0.71940340 |
| 96 | MP0010307_abnormal_tumor_latency | 0.71042491 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.70518078 |
| 98 | MP0003329_amyloid_beta_deposits | 0.69386446 |
| 99 | MP0003111_abnormal_nucleus_morphology | 0.68728959 |
| 100 | MP0005023_abnormal_wound_healing | 0.67427925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.58886958 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.58886958 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.58886958 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.07469163 |
| 5 | Optic neuritis (HP:0100653) | 4.07469163 |
| 6 | Orchitis (HP:0100796) | 4.01676654 |
| 7 | Increased IgM level (HP:0003496) | 3.89453764 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 3.59693114 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.58246487 |
| 10 | J-shaped sella turcica (HP:0002680) | 3.47051535 |
| 11 | Myositis (HP:0100614) | 3.29171973 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.25456366 |
| 13 | Autoimmune hemolytic anemia (HP:0001890) | 3.25113872 |
| 14 | Pulmonary infiltrates (HP:0002113) | 3.21581167 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.21412592 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.19271311 |
| 17 | Keratoconjunctivitis (HP:0001096) | 3.16547665 |
| 18 | Keratoconjunctivitis sicca (HP:0001097) | 3.13415448 |
| 19 | Arterial thrombosis (HP:0004420) | 3.02775415 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01446736 |
| 21 | Vasculitis (HP:0002633) | 2.88291211 |
| 22 | Abnormality of the lumbar spine (HP:0100712) | 2.86704644 |
| 23 | Gastrointestinal infarctions (HP:0005244) | 2.83002291 |
| 24 | Beaking of vertebral bodies (HP:0004568) | 2.78293480 |
| 25 | Joint swelling (HP:0001386) | 2.74552648 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.73796617 |
| 27 | Abnormality of T cell number (HP:0011839) | 2.69227015 |
| 28 | Anorexia (HP:0002039) | 2.66260890 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63727251 |
| 30 | Mucopolysacchariduria (HP:0008155) | 2.63727251 |
| 31 | Deep venous thrombosis (HP:0002625) | 2.60666694 |
| 32 | Recurrent viral infections (HP:0004429) | 2.60298787 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.57187872 |
| 34 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.57187872 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.57187872 |
| 36 | Myocardial infarction (HP:0001658) | 2.55753617 |
| 37 | Thoracic kyphosis (HP:0002942) | 2.55566014 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 2.53023867 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.52687971 |
| 40 | Loss of speech (HP:0002371) | 2.52555704 |
| 41 | Amaurosis fugax (HP:0100576) | 2.46647910 |
| 42 | Granulocytopenia (HP:0001913) | 2.44802454 |
| 43 | Gingival bleeding (HP:0000225) | 2.44277709 |
| 44 | Urticaria (HP:0001025) | 2.41192724 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.40362885 |
| 46 | Eosinophilia (HP:0001880) | 2.39912455 |
| 47 | Flat acetabular roof (HP:0003180) | 2.38797624 |
| 48 | Alopecia of scalp (HP:0002293) | 2.37110224 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.36707508 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.34950057 |
| 51 | Meningitis (HP:0001287) | 2.27599097 |
| 52 | Cheilitis (HP:0100825) | 2.26864868 |
| 53 | Abnormality of T cells (HP:0002843) | 2.26483559 |
| 54 | Increased serum ferritin (HP:0003281) | 2.24885933 |
| 55 | Spondylolisthesis (HP:0003302) | 2.24635953 |
| 56 | Gangrene (HP:0100758) | 2.24370435 |
| 57 | Abnormality of the thoracic spine (HP:0100711) | 2.21500322 |
| 58 | Polyneuropathy (HP:0001271) | 2.21121792 |
| 59 | Nonimmune hydrops fetalis (HP:0001790) | 2.18775015 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.17564434 |
| 61 | Keratitis (HP:0000491) | 2.17412484 |
| 62 | Mitral stenosis (HP:0001718) | 2.12578435 |
| 63 | Subacute progressive viral hepatitis (HP:0006572) | 2.11354468 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11126494 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11126494 |
| 66 | Glomerulopathy (HP:0100820) | 2.10897994 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.10121108 |
| 68 | Leukocytosis (HP:0001974) | 2.08583522 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.06957432 |
| 70 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05820924 |
| 71 | T lymphocytopenia (HP:0005403) | 2.04450235 |
| 72 | Encephalitis (HP:0002383) | 2.03282816 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.02900050 |
| 74 | Agammaglobulinemia (HP:0004432) | 2.01513641 |
| 75 | Pustule (HP:0200039) | 2.01406389 |
| 76 | Recurrent skin infections (HP:0001581) | 2.00087641 |
| 77 | Progressive muscle weakness (HP:0003323) | 1.99739515 |
| 78 | Deformed sella turcica (HP:0002681) | 1.99391312 |
| 79 | Hypochromic anemia (HP:0001931) | 1.97792439 |
| 80 | Premature skin wrinkling (HP:0100678) | 1.95710848 |
| 81 | Thrombophlebitis (HP:0004418) | 1.95587559 |
| 82 | Increased IgE level (HP:0003212) | 1.95526994 |
| 83 | Flared iliac wings (HP:0002869) | 1.94309341 |
| 84 | Abnormality of eosinophils (HP:0001879) | 1.94140439 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92770382 |
| 86 | Vertebral compression fractures (HP:0002953) | 1.90536339 |
| 87 | Obstructive lung disease (HP:0006536) | 1.89030089 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89030089 |
| 89 | Hemoptysis (HP:0002105) | 1.88700590 |
| 90 | Fatigue (HP:0012378) | 1.87883059 |
| 91 | Epistaxis (HP:0000421) | 1.86551551 |
| 92 | Prostate neoplasm (HP:0100787) | 1.86050170 |
| 93 | Broad face (HP:0000283) | 1.85538152 |
| 94 | Abnormality of the pericardium (HP:0001697) | 1.84215685 |
| 95 | Cellulitis (HP:0100658) | 1.83655661 |
| 96 | Anhidrosis (HP:0000970) | 1.80586453 |
| 97 | Viral hepatitis (HP:0006562) | 1.79716272 |
| 98 | Thickened calvaria (HP:0002684) | 1.78866553 |
| 99 | Purpura (HP:0000979) | 1.76498396 |
| 100 | Pulmonary embolism (HP:0002204) | 1.75095816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.14368285 |
| 2 | MAP3K14 | 3.96645235 |
| 3 | IRAK3 | 3.70657369 |
| 4 | MAP2K3 | 2.73325443 |
| 5 | PRPF4B | 2.51494305 |
| 6 | CDK12 | 2.50736089 |
| 7 | SCYL2 | 2.44283015 |
| 8 | MAP4K1 | 2.32717511 |
| 9 | FES | 2.27809367 |
| 10 | MAP3K13 | 2.24241452 |
| 11 | SMG1 | 2.15586557 |
| 12 | FGFR4 | 2.13106839 |
| 13 | BLK | 2.00213548 |
| 14 | EPHB1 | 1.95731748 |
| 15 | TGFBR2 | 1.91993867 |
| 16 | TAOK2 | 1.87738943 |
| 17 | MATK | 1.84512786 |
| 18 | TXK | 1.84344924 |
| 19 | ERN1 | 1.74623640 |
| 20 | TYK2 | 1.60815983 |
| 21 | TAOK1 | 1.59865600 |
| 22 | TBK1 | 1.59670628 |
| 23 | MAP3K3 | 1.58562600 |
| 24 | IKBKE | 1.56792883 |
| 25 | KDR | 1.45785185 |
| 26 | BCR | 1.39830334 |
| 27 | JAK3 | 1.38867897 |
| 28 | TESK2 | 1.38394698 |
| 29 | INSRR | 1.35919250 |
| 30 | ZAP70 | 1.33923408 |
| 31 | ARAF | 1.28760862 |
| 32 | CSK | 1.24924786 |
| 33 | IKBKB | 1.24202808 |
| 34 | CDK4 | 1.20477507 |
| 35 | KIT | 1.20443603 |
| 36 | IRAK1 | 1.18373236 |
| 37 | MAP3K1 | 1.18267790 |
| 38 | RIPK4 | 1.13080562 |
| 39 | MELK | 1.12356866 |
| 40 | CHUK | 1.10619946 |
| 41 | PAK4 | 1.08303160 |
| 42 | MAP3K8 | 1.07040070 |
| 43 | JAK1 | 1.03247132 |
| 44 | MAP3K6 | 1.02412338 |
| 45 | IRAK2 | 1.00812682 |
| 46 | PIM2 | 0.99260001 |
| 47 | TRIB3 | 0.99130877 |
| 48 | FGFR3 | 0.98954568 |
| 49 | CDK6 | 0.94505462 |
| 50 | NME2 | 0.94433989 |
| 51 | NEK9 | 0.87838334 |
| 52 | STK10 | 0.84883277 |
| 53 | MAP3K5 | 0.84863954 |
| 54 | TAOK3 | 0.82410121 |
| 55 | LYN | 0.81384553 |
| 56 | CSF1R | 0.80951853 |
| 57 | BRAF | 0.73955116 |
| 58 | PDK2 | 0.73392450 |
| 59 | CLK1 | 0.72827909 |
| 60 | MAP3K11 | 0.70900677 |
| 61 | HCK | 0.69888058 |
| 62 | KSR2 | 0.69096265 |
| 63 | ICK | 0.67135857 |
| 64 | BCKDK | 0.65990847 |
| 65 | PIM1 | 0.64386981 |
| 66 | FGR | 0.62010876 |
| 67 | PBK | 0.60952885 |
| 68 | VRK2 | 0.57883553 |
| 69 | PDPK1 | 0.57702491 |
| 70 | MAPKAPK2 | 0.57385135 |
| 71 | CDC42BPA | 0.57171618 |
| 72 | MAP2K2 | 0.55042156 |
| 73 | LCK | 0.54522179 |
| 74 | MAP3K2 | 0.53518996 |
| 75 | TTN | 0.50963607 |
| 76 | MST1R | 0.50591749 |
| 77 | PDK1 | 0.49704728 |
| 78 | BUB1 | 0.49683069 |
| 79 | FER | 0.49432258 |
| 80 | SYK | 0.48537994 |
| 81 | GRK6 | 0.47291846 |
| 82 | PAK2 | 0.47102186 |
| 83 | BTK | 0.45902688 |
| 84 | PRKCQ | 0.45715761 |
| 85 | MARK3 | 0.43285809 |
| 86 | CDK9 | 0.43078249 |
| 87 | MAPK11 | 0.39959558 |
| 88 | WNK1 | 0.39899492 |
| 89 | STK24 | 0.39832598 |
| 90 | RAF1 | 0.37567669 |
| 91 | JAK2 | 0.37479373 |
| 92 | STK4 | 0.37024235 |
| 93 | MST4 | 0.36795930 |
| 94 | PRKD2 | 0.36278108 |
| 95 | MOS | 0.34607380 |
| 96 | MAP3K4 | 0.32577077 |
| 97 | BMPR2 | 0.30537072 |
| 98 | FLT3 | 0.30166289 |
| 99 | RPS6KC1 | 0.29488368 |
| 100 | RPS6KL1 | 0.29488368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.85831828 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.81092869 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.50187853 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.43929212 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.42522077 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.23632174 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.22671205 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07667204 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03697165 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.99429618 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96201574 |
| 12 | Influenza A_Homo sapiens_hsa05164 | 1.96161518 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.89439361 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87432837 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.81000347 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79499030 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78134341 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.77850329 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73649054 |
| 20 | Hepatitis B_Homo sapiens_hsa05161 | 1.66481587 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60816278 |
| 22 | Apoptosis_Homo sapiens_hsa04210 | 1.59711029 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.55312869 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.55234198 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50929200 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46678115 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34799022 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.32154151 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.31698843 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30728713 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.28895041 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27556040 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.26026816 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21796337 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.17146523 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.16773836 |
| 37 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.16654721 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15977535 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.15308494 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13373791 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10452327 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09903172 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.07649539 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06887360 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04948936 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01777072 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00078823 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97164286 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97077277 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95781264 |
| 51 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94465081 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91128940 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90321786 |
| 54 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87252334 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87165026 |
| 56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86223905 |
| 57 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83818765 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82936179 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82622926 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82085442 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81376355 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78792230 |
| 63 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77979989 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73817561 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71340123 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.70513231 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.69567997 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67874410 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66128456 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64860379 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.62491686 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62433304 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62003742 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60646313 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59832015 |
| 76 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59172708 |
| 77 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.59037275 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.58995425 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58352074 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56937387 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.56331830 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56051726 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55001958 |
| 84 | DNA replication_Homo sapiens_hsa03030 | 0.54464844 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53649573 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53253913 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52430756 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52332766 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.51963483 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51916003 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49673756 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48607553 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42425237 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42383441 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.41819291 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41557542 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41526270 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | 0.41415378 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39704516 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39360121 |

